Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia) (CHO-CAP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00812084|
Recruitment Status : Completed
First Posted : December 19, 2008
Last Update Posted : June 12, 2015
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
G.A. de Wit, UMC Utrecht
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Mangen MJ, Huijts SM, Bonten MJ, de Wit GA. The impact of community-acquired pneumonia on the health-related quality-of-life in elderly. BMC Infect Dis. 2017 Mar 14;17(1):208. doi: 10.1186/s12879-017-2302-3.
Mangen MJ, Bolkenbaas M, Huijts SM, van Werkhoven CH, Bonten MJ, de Wit GA. Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L. Health Qual Life Outcomes. 2017 Jan 6;15(1):3. doi: 10.1186/s12955-016-0577-5.